ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.1139G>T (p.Gly380Val)

dbSNP: rs766006685
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV002254800 SCV002525889 uncertain significance Glanzmann thrombasthenia 2024-04-16 reviewed by expert panel curation The ITGA2B missense variant NM_000419.5:c.1139G>T replaces the glycine residue with a valine residue (p.Gly380Val). This variant has been observed in homozygosity in one individual with a phenotype specific for Glanzmann's thrombasthenia (GT) (GT28, PMID: 16463284; PM3_supporting). All requirements for PP4_Moderate are met (GT28 in PMID: 16463284): history of bleeding and impaired aggregation to at least two agonists, but normal or only mildly reduced agglutination with ristocetin. This variant is absent from gnomADv4.0 (PM2_supporting) and the in silico meta-predictor REVEL score for this variant is 0.853, exceeding the VCEP-established threshold of ≥0.7 and suggestive of a damaging effect on protein function (PP3). Another missense change at this amino acid codon has been observed (c.1139G>A (p.Gly380Asp), Patient GM in PMID: 12083483) and classified as uncertain significance by the Platelet Disorders VCEP. In summary, this variant meets criteria to be classified as uncertain significance for GT. GT-specific criteria applied: PP4_moderate, PM2_supporting, PM3_supporting, and PP3.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.